Login to Your Account

Earnings Roundup

Monday, July 23, 2012
• Cubist Pharmaceuticals Inc., of Lexington, Mass., reported second-quarter revenues of $230.6 million, and earnings per share of 58 cents, solidly beating analyst estimates of 45 cents per share. The company reported net revenues of $212 million for antibiotic Cubicin (daptomycin), an increase of 20 percent over the second quarter of 2011.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription